Hypothalamic NPY status during positive energy balance and the effects of the NPY antagonist, BW1229U91, on the consumption of highly palatable energy-rich diet

Peptides

Volumn 20, Issue 3, 1999, Pages 367-372

  Widdowson, Peter S ^a   Henderson, Lynne ^a   Pickavance, Lucy ^a   Buckingham, Robin ^b   Tadayyon, Mohammad ^b   Arch, Jonathan R S ^b   Williams, Gareth ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

BW1229U91; Energy balance; Hypothalamus; Neuropeptide Y; Obesity

Indexed keywords

GR 231118; INSULIN; LEPTIN; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; ENERGY BALANCE; FOOD INTAKE; HYPERINSULINEMIA; HYPERPHAGIA; HYPOTHALAMUS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; NORTHERN BLOTTING; OBESITY; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION;

ANIMALS; DIET; ENERGY METABOLISM; HYPOTHALAMUS; MALE; NEUROPEPTIDE Y; PEPTIDES, CYCLIC; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y;

EID: 0032853212     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(99)00044-3     Document Type: Article

References (32)

1. Bchini-Hooft Van Huisduijnen O., Roher-Jeanrenaud F., Jeanrenaud B. Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats potential regulation thereof by corticotrophin-releasing factor . J Neuroendocrinol. 5:1993;381-386.
2. Becker D.J., Ongemba L.N., Brichard V., Henquin J.-C., Brichard S.M. Diet- and diabetes-induced changes of ob gene expression in rat adipose tissue. FEBS Lett. 371:1995;324-328.
3. Billington C.J., Briggs J., Grace M., Levine A.S. Effects of intracerebroventricular injection of NPY on energy metabolism. Am J Physiol. 260:1991;R321-R327.
4. Currie P.J., Coscina D.V. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus. Peptides. 16:1995;599-604.
5. Dryden S., Frankish H., Wang Q., Williams G. Neuropeptide Y and energy balance one way ahead for the treatment of obesity? Eur J Clin Invest. 24:1994;293-308.
6. Dryden S., Pickavance L., Frankish H.M., Williams G. Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res. 690:1995;185-188.
7. Egawa M., Yoshimatsu H., Bray G.A. Neuropeptide Y suppresses sympathetic activity to interscapular brown adipose tissue. Am J Physiol. 260:1991;R328-R334.
8. Gerald C.C., Walker M.W., Criscione L., Gustafson E.L., Batzl-Hartmann C., Smith K.E., Vaysse P., Durkin M.M., Laz T.M., Linemeyer D.L., Schaffhauser A.O., Whitebread S., Hofbauer K.G., Taber R.I., Branchek T.A., Weinshank R.L. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature (London). 382:1996;168-171.
9. Grundemar L., Håkanson R. Neuropeptide Y effector system perspectives for drug development . TIPS. 15:1994;153-159.
10. Håkanson M.-L., Hulting A.-L., Meister B. Expression of leptin receptor mRNA in hypothalamic arcuate nucleus - relationship with NPY neurones. NeuroReport. 7:1996;3087-3092.
11. Hedge S.S., Bonhaus D.W., Stanley W., Eglen R.M., Moy T.M., Loeb M., Shelly S.G., Desouza A., Krstenansky J. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide-Y-Y1 receptor antagonist. J Pharmacol Exp Ther. 275:1995;1261-1266.
12. Jeanrenaud B. Central nervous system and peripheral abnormalities clues to the understanding of obesity and NIDDM . Diabetologia. 37:(suppl 2):1994;S170-S178.
13. Kalra P.S., Xu B., Duke M.G. Two distinct leptin-NPY signaling modalities underlie hyperphagia in CNS-dependent obesity models. Peptides. 71:1997;218.
14. Kanatani A., Ishihara A., Asahi A., Tanaka T., Ozaki S., Ihara M.L. Potent neuropeptide Y Y1 receptor antagonist, 1229U91 blockade of neuropeptide Y-induced and physiological food intake . Endocrinology. 137:1996;3177-3182.
15. Kanatani A., Fukami T., Fukurada T., Iwaasa T., MacNeil D., Van Der Ploeg L., Ihara M. Y5 receptors are not involved in physiologically relevant feeding in rodents. Peptides. 71:1997;212.
16. Mantzoros C.S., Frederich R.-C., Qu D., Lowell B.B., Maratos-Flier J.S. Severe leptin resistance in brown fat-deficient uncoupling protein promotor-driven diphtheria toxin A mice despite suppression of hypothalamic neuropeptide Y and circulating corticosterone concentrations. Diabetes. 47:1998;230-238.
17. Matthews J.E., Jansen M., Lyerly D., Cox R., Chen W.-J., Koller K.K., Daniels A.J. Pharmacological characterization and selectivity of the NPY antagonist GR2331118 (1229U91) for different NPY receptors. Regul Pept. 72:1997;113-119.
18. Mercer J.G., Moar K.M., Rayner D.V., Trayhurn P., Hoggard N. Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice. FEBS Lett. 402:1997;185-188.
19. McCarthy H.D., McKibbin P.E., Holloway B., Mayers R., Williams G. Hypothalamic neuropeptide Y receptor characteristics and NPY-induced feeding responses in lean and obese Zucker rats. Life Sci. 49:1991;1491-1497.
20. McKibbin P.E., Cotton S.J., McMillan S., Holloway B., Mayers R., McCarthy H.D., Williams G. Altered neuropeptide Y concentrations in specific hypothalamic regions of obese (fa/fa) Zucker rats. Diabetes. 40:1991;1423-1429.
21. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1982;Academic Press, New York.
22. Sancora G., Kershaw M., Finkelstein J.A., White J.D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 127:1996;730-737.
23. Smith F.L., Campfield L.A., Moschera J.A., Ballon P.S., Burn P. Feeding inhibition by neuropeptide Y. Nature (London). 382:1996;307.
24. Stanley B.G., Kyhouli S.E., Lampert S., Leibowitz S.F. Neuropeptide Y chronically injected into the hypothalamus a powerful neurochemical inducer of hyperphagia and obesity . Peptides. 7:1986;1189-1192.
25. Stanley B.G., Magdalin W., Seifari A., Thomas W.J., Leibowitz S.F. The perifornical area the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s) . Brain Res. 604:1993;304-317.
26. Stephens T.W., Basinski M., Bristow P.K., Bue-Valleskey J.M., Burgett S.G., Craft L., Hale J., Hoffmann J., Hsiung H.M., Krianciunas A., MacKellar W., Posteck P.R., Schoner B., Smith D., Tinsley F.C., Zhnag X.-Y., Heinman M. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature (London). 377:1995;530-532.
27. Vettor R., Zarjevski N., Cusin I., Rohner-Jeanrenaud F., Jeanrenaud B. Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia. 37:1994;1202-1208.
28. Wang Q., Bing C., Al-Barazanji K., Mossakowaska D.E., Wang X.-M., McBay D.L., Neville W.A., Tadayyon M., Pickavance L., Dryden S., Thomas M.E., McHale M.T., Gloyer I.S., Wilson S., Buckingham R., Arch J.R.S., Trayhurn P., Williams G. Interactions between leptin and hypothalamic neuropeptide Y neurons in the control of food intake and energy homeostasis in the rat. Diabetes. 46:1997;335-341.
29. Widdowson P.S. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat relationship to the Y5 'feeding' receptor . Brain Res. 758:1997;17-25.
30. Widdowson P.S., Upton R., Buckingham R., Arch J., Williams G. Attenuated response in the rat to intracerebroventricular injections of leptin on food consumption in diet-induced obesity. Diabetes. 46:1997;1782-1785.
31. Widdowson P.S., Upton R., Henderson L., Buckingham R., Wilson S., Williams G. Diametric regional changes in NPY receptor density during dietary restriction and dietary-induced obesity in the rat brain. Brain Res. 774:1997;1-10.
32. Wilding J.P.H., Gilbey S.G., Mannan M., Aslam N., Ghatei M.A., Bloom S.R. Increased neuropeptide Y content in individual hypothalamic nuclei, but not neuropeptide Y mRNA, in diet-induced obesity in rats. J Endocrinol. 132:1992;299-304.